Remsima SC (infliximab)

pCPA File Number: 21440
Negotiation Status:
Concluded without agreement
Indication(s):
Rheumatoid Arthritis
Sponsor/Manufacturer:
Celltrion Healthcare Canada Ltd.
CDA-AMC Project Number:
SR0659-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: